Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

RNTXRNTX
Showing 8 of 15 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in REIN THERAPEUTICS INC

GEODE CAPITAL MANAGEMENT, LLC holds 733,139 shares of RNTX (REIN THERAPEUTICS INC), worth $762,540 as of 2026-Q2. The position was increased (+112.7% shares).

Current Value

$762,540

Current Shares

733,139

Total Value Change

-$51,230

Total Shares Change

+503,322

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
733,139
+112.7%
$762,5400.0%$1.04
27
2026-Q1
Increased
344,690
+21.1%
$448,1850.0%$1.15
20
2025-Q4
Increased
284,555
+15.1%
$330,1590.0%$1.07
18
2025-Q3
Increased
247,311
+0.8%
$283,2490.0%$1.15
16
2025-Q2
Decreased
245,455
-0.3%
$343,7250.0%$1.47
0
2025-Q1
Increased
246,096
+1.9%
$435,7240.0%$1.70
17
2024-Q4
Increased
241,437
+5.1%
$555,4800.0%$2.32
17
2024-Q3
Increased
229,817
+34.8%
$813,7700.0%$3.65
32

Other major holders of RNTX: VANGUARD CAPITAL MANAGEMENT LLC, CITADEL ADVISORS LLC, Alyeska Investment Group, L.P., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used